STOCK TITAN

Globe Life (NYSE: GL) director David Rodriguez reports 1,373-share stock award

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Globe Life Inc. director David A. Rodriguez reported acquiring common stock of the company. On 01/02/2026, he acquired 1,373 shares of common stock at a stated price of $0, which typically reflects an equity award rather than an open‑market purchase. Following this transaction, he beneficially owned 7,226.4852 shares of Globe Life common stock directly.

An explanatory note states that this amount includes 35.8599 dividend right restricted stock units that were acquired in connection with restricted stock units since the date of his last report.

Positive

  • None.

Negative

  • None.
Insider Rodriguez David A
Role Director
Type Security Shares Price Value
Grant/Award Common Stock 1,373 $0.00 --
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 7,226.485 shares (Direct); Common Stock — 0 shares (Indirect, Not applicable)
Footnotes (1)
  1. [object Object]
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Rodriguez David A

(Last) (First) (Middle)
C/O GLOBE LIFE INC.
3700 SOUTH STONEBRIDGE DRIVE

(Street)
MCKINNEY TX 75070

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
GLOBE LIFE INC. [ GL ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
01/02/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 01/02/2026 A 1,373 A $0 7,226.4852(1) D
Common Stock 0 I Not applicable
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Includes 35.8599 dividend right restricted stock units acquired upon restricted stock units since the date of last report.
David A. Rodriguez by /s/ Chris T. Moore, Attorney-in-fact 01/05/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Globe Life (GL) disclose for David A. Rodriguez?

Globe Life disclosed that director David A. Rodriguez acquired 1,373 shares of common stock on 01/02/2026 at a stated price of $0.

How many Globe Life (GL) shares does David A. Rodriguez now beneficially own?

After the reported transaction, David A. Rodriguez beneficially owned 7,226.4852 shares of Globe Life Inc. common stock directly.

Was the Globe Life (GL) insider transaction a purchase on the open market?

The filing reports the acquisition of 1,373 shares at a stated price of $0, which indicates an equity award or similar grant rather than an open‑market purchase.

What are the dividend right restricted stock units mentioned for Globe Life (GL)?

The explanation states that the total beneficial ownership includes 35.8599 dividend right restricted stock units acquired in connection with restricted stock units since the date of the last report.

What is the role of David A. Rodriguez at Globe Life (GL)?

David A. Rodriguez is identified in the filing as a Director of Globe Life Inc..

Is the Globe Life (GL) Form 4 filed by a single reporting person?

Yes. The document indicates that the Form is filed by one reporting person, referring to David A. Rodriguez.